Health
Biomom Reinvents "Snow" with Five-Layer Safety Packaging -- Stronger Protection and Greater Convenience for Kids' Probiotics
SEOUL, South Korea, Nov. 3, 2025 /PRNewswire/ -- Health supplement brand Biomom has introduced upgraded, hygienic packaging for its flagship probiotic "Biomom Snow." The renewal features five-layer safety stick and pillow packaging designed to enhance probiotic protection and ensure a more conve...
2025-11-03 14:00
787
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'
YONGIN, South Korea, Nov. 3, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based inSouth Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been published in the international journal Vaccine. BARYTHRA...
2025-11-03 13:26
960
Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer
HONG KONG, Nov. 2, 2025 /PRNewswire/ -- Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for first-line treatment of triple-negative breast cancer (TNBC) has been granted Breakthrough Therapy Desi...
2025-11-03 12:12
1069
MALAYSIA HEALTHCARE TRAVEL COUNCIL STRENGHTENS REGIONAL PRESENCE IN MEDAN THROUGH ASTINDO TRAVEL FAIR 2025
MEDAN, Indonesia, Nov. 3, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) continues to advance its regional outreach by participating in the ASTINDO Travel Fair (ATF) 2025, held inMedan, Indonesia. The event serves as one of the largest tourism exhibitions in the country, gathe...
2025-11-03 11:37
1042
OMANI PATIENTS GAIN DIRECT ACCESS TO MALAYSIAN MEDICAL SPECIALISTS THROUGH WEEK-LONG HEALTHCARE ACTIVATION
SEEB, Oman, Nov. 3, 2025 /PRNewswire/ -- Malaysia Healthcare Week opens at City Centre Mall, Seeb, marking the first majorMiddle East activation under the Malaysia Year of Medical Tourism (MYMT) 2026. The week-long programme connects Omani patients with Malaysian medical specialists through publi...
2025-11-03 11:19
1140
Oxford Instruments introduces the witec360 Raman Microscope with Hexalight Spectrometer to advance research in Singapore and across Southeast Asia
LONDON, Nov. 3, 2025 /PRNewswire/ -- Oxford Instruments today announced the launch of its witec360Raman microscope with the Hexalight spectrometer, setting a new benchmark in confocal Raman imaging and analysis. The new system delivers unprecedented optical performance, automation, and flexibilit...
2025-11-03 09:00
1137
Caregility and MOD3RN Care Partner to Modernise Healthcare Delivery in Australia
WALL, N.J. and BARANGAROO, Australia, Nov. 3, 2025 /PRNewswire/ -- Caregility Corporation, a global enterprise telehealth leader dedicated to connecting care for patients and clinicians everywhere through innovative virtual care and AI-powered solutions, today announced a strategic reseller partn...
2025-11-03 05:30
1126
Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic lateral sclerosis (ALS) has officially initiated the phase 2/3 clinical trial and completed the ...
2025-10-31 21:00
2079
Bio Farma Indonesia Leads Global Vaccine Manufacturers as Host of the 26th DCVMN AGM in Bali
BALI, Indonesia, Oct. 31, 2025 /PRNewswire/ -- Bali, October 29, 2025, Indonesia , throughBio Farma, is hosting the 26th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufacturers Network (DCVMN) inBali on October 29–31, 2025. The forum brings together vaccine manufacturers, ...
2025-10-31 20:01
2455
Elevaris Medical Devices Names New Chief Engineering and Operations Officer
BOSTON, Oct. 31, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract
Development and Manufacturing Organization for industry-leading multi-national
healthcare companies, announced the appointment of its new Chief Engineering
and Operations Officer,Salvador Montes.
2025-10-31 20:00
1148
Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer
– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with differentiated thyroid cancer – TOKYO, Oct. 31, 2025 /PRNewswire/ -- Alpha Fusion Inc. (Headquarters: Chiyoda-ku,Tokyo; CEO: Sunao Fujioka; hereinafter "Alpha Fusion") today announced the in...
2025-10-31 20:00
1513
Kexing Biopharm Showcases Global Strategy and Partnership Opportunities at CPHI Frankfurt 2025
FRANKFURT, Germany, Oct. 31, 2025 /PRNewswire/ -- From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world's most influential pharmaceutical exhibitions, presenting its key product portfolio and international commercialization solutions to partners from glo...
2025-10-31 19:50
1598
AXA BetterMe Weekend Celebrates Its 5th Anniversary with over 13,000 participants
Spreading positivity across the city and inspiring everyone to achieve their BetterMe HONG KONG, Oct. 31, 2025 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") successfully concluded its annual community carnival, the "AXA BetterMe Weekend ", held from 25 to 26 October atAXA WONDERLAND, WestK. Cel...
2025-10-31 18:04
1292
JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an Amendment to its strategic collaboration agreement with R...
2025-10-31 17:38
1145
Xinhua Silk Road: Chinese biz leaders hold talks to explore cultural inheritance, innovation
BEIJING, Oct. 31, 2025 /PRNewswire/ -- On Tuesday, an in-depth talk between board chairmen of Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang) and Kweichow Moutai Group highlighted joint effort to promote inheritance and innovation of traditional Chinese culture. After discussi...
2025-10-31 16:15
855
Catalent Debuts New Corporate Brand, Elevating Customer Service Excellence by "Championing the Missions that Matter™"
TAMPA, Fla., Oct. 31, 2025 /PRNewswire/ -- Catalent, Inc., a leading global contract development and manufacturing organization, today unveiled its new corporate brand, marking a strategic evolution that underscores the company's commitment to delivering unparalleled customer service and its focu...
2025-10-31 08:30
1043
Singapore Court Confirms GNC's Rights to Assume Former GNC Store Leases from LAC, Setting the Stage for Continued Growth in Singapore
Ruling reduces market confusion and reinforces GNC's science‑backed leadership;
company accelerates partnership with Watsons to deliver best‑in‑class wellness
solutions for consumers
PITTSBURGH, Oct. 31, 2025 /PRNewswire/ -- GNC
2025-10-31 07:00
1310
IMG Wins Two 2025 Travel Weekly Magellan Awards
INDIANAPOLIS, Oct. 30, 2025 /PRNewswire/ -- IMG
2025-10-30 21:00
924
NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries
* NovaBridge subsidiary Visara assigned its exclusive license to Everest Medicines to accelerate the development of potential best-in-class therapy for wet AMD, VIS-101, leveraging Everest Medicines' strong clinical and commercialization expertise inGreater China and other Asian markets * Nov...
2025-10-30 16:15
1053
U.S. FDA grants interchangeability designation to Celltrion's denosumab biosimilars, STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo)
* The U.S. FDA approved STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) as interchangeable with the reference products PROLIA® (denosumab) and XGEVA® (denosumab), respectively, for all approved indications, effective as ofOctober 29, 2025 * The interchangeability (IC) designations o...
2025-10-30 15:28
1017
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15
Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 311 media titles]
2025-12-04 16:00
Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 301 media titles]
2025-12-09 13:31
World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
4404
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
3598
MALAYSIA REMAINS COMMITTED TO ACCELERATE TRANSFORMATIVE SOLUTIONS FOR A SUSTAINABLE AND INCLUSIVE FUTURE
2025-12-06 00:41
3564
PAVS Achieves 18,037% YoY Revenue Increase in 2025 Interim Results
2025-12-05 21:45
3259